Penumbra ROA 2014-2018 | PEN
Current and historical return on assets (ROA) values for Penumbra (PEN) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Penumbra ROA for the three months ending September 30, 2018 was 3.53%.
| Penumbra ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2018-09-30 | $0.01B | $0.50B | 1.63% |
| 2018-06-30 | $0.03B | $0.50B | 5.61% |
| 2018-03-31 | $0.01B | $0.49B | 2.60% |
| 2017-12-31 | $0.00B | $0.48B | 0.90% |
| 2017-09-30 | $-0.01B | $0.46B | -1.75% |
| 2017-06-30 | $0.01B | $0.42B | 1.39% |
| 2017-03-31 | $0.01B | $0.42B | 3.06% |
| 2016-12-31 | $0.02B | $0.31B | 5.15% |
| 2016-09-30 | $0.02B | $0.30B | 6.43% |
| 2016-06-30 | $0.01B | $0.28B | 2.22% |
| 2016-03-31 | $0.00B | $0.28B | 1.00% |
| 2015-12-31 | $0.00B | $0.26B | 0.76% |
| 2015-09-30 | $0.00B | $0.26B | 0.00% |
| 2015-06-30 | $-0.00B | $0.00B | inf% |
| 2015-03-31 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $4.563B | $0.334B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $94.795B | 22.09 |
| Intuitive Surgical (ISRG) | United States | $58.866B | 57.92 |
| Edwards Lifesciences (EW) | United States | $33.885B | 36.26 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $21.007B | 14.20 |
| IDEXX Laboratories (IDXX) | United States | $16.903B | 48.28 |
| ABIOMED (ABMD) | United States | $14.665B | 105.38 |
| DexCom (DXCM) | United States | $13.065B | 0.00 |
| Hologic (HOLX) | United States | $12.419B | 19.17 |
| Teleflex (TFX) | United States | $11.776B | 26.73 |
| Varian Medical Systems (VAR) | United States | $11.360B | 28.27 |
| STERIS (STE) | United Kingdom | $9.266B | 24.59 |
| Masimo (MASI) | United States | $6.147B | 39.86 |
| LivaNova (LIVN) | United Kingdom | $4.394B | 28.20 |
| Globus Medical (GMED) | United States | $4.169B | 26.13 |
| Integra LifeSciences Holdings (IART) | United States | $3.907B | 19.03 |
| Wright Medical Group (WMGI) | Netherlands | $3.570B | 0.00 |
| Cantel Medical (CMD) | United States | $3.296B | 32.51 |
| Inogen (INGN) | United States | $3.100B | 66.91 |
| Integer Holdings (ITGR) | United States | $2.569B | 21.50 |
| Tandem Diabetes Care (TNDM) | United States | $2.468B | 0.00 |
| Glaukos (GKOS) | United States | $2.124B | 0.00 |
| OPKO Health (OPK) | United States | $2.116B | 0.00 |
| Halyard Health (AVNS) | United States | $2.078B | 18.73 |
| Nevro (NVRO) | United States | $1.225B | 0.00 |
| Luminex (LMNX) | United States | $1.127B | 40.77 |
| Natus Medical (BABY) | United States | $1.112B | 23.37 |
| Tactile Systems Technology (TCMD) | United States | $1.101B | 175.26 |
| Pacific Biosciences Of California (PACB) | United States | $1.065B | 0.00 |
| CryoLife (CRY) | United States | $1.023B | 89.26 |
| Orthofix (OFIX) | United States | $0.954B | 27.54 |
| Accelerate Diagnostics (AXDX) | United States | $0.862B | 0.00 |
| Intersect ENT (XENT) | United States | $0.855B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.827B | 48.92 |
| AngioDynamics (ANGO) | United States | $0.754B | 24.46 |
| ViewRay (VRAY) | United States | $0.673B | 0.00 |
| AxoGen (AXGN) | United States | $0.637B | 0.00 |
| Veracyte (VCYT) | United States | $0.636B | 0.00 |
| TransEnterix (TRXC) | United States | $0.575B | 0.00 |
| Si-Bone (SIBN) | United States | $0.535B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.406B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.403B | 0.00 |
| Sientra (SIEN) | United States | $0.397B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.392B | 0.00 |
| Accuray (ARAY) | United States | $0.341B | 0.00 |
| Fluidigm (FLDM) | United States | $0.340B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.335B | 0.00 |
| IRadimed (IRMD) | United States | $0.291B | 75.97 |
| SeaSpine Holdings (SPNE) | United States | $0.285B | 0.00 |
| Neuronetics (STIM) | United States | $0.269B | 0.00 |
| Nuvectra (NVTR) | United States | $0.264B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.260B | 40.90 |
| Pulse Biosciences (PLSE) | United States | $0.241B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.224B | 38.63 |
| Corindus Vascular Robotics (CVRS) | United States | $0.218B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.213B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.164B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.129B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.123B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.108B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.080B | 0.00 |
| EDAP TMS (EDAP) | France | $0.074B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.073B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.068B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.068B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.066B | 0.00 |
| Vermillion (VRML) | United States | $0.051B | 0.00 |
| Electromed (ELMD) | United States | $0.042B | 20.04 |
| OBALON THERPTCS (OBLN) | United States | $0.040B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.039B | 0.00 |
| ConforMIS (CFMS) | United States | $0.034B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.032B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.031B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.028B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.027B | 0.00 |
| PAVmed (PAVM) | United States | $0.025B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.025B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.024B | 0.00 |
| Dynatronics (DYNT) | United States | $0.022B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.022B | 0.00 |
| Neovasc (NVCN) | Canada | $0.017B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.014B | 10.78 |
| Bioanalytical Systems (BASI) | United States | $0.013B | 65.00 |
| Nanovibronix (NAOV) | United States | $0.013B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.013B | 0.00 |
| Presbia (LENS) | Ireland | $0.010B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.008B | 0.00 |
| Micron Solutions (MICR) | United States | $0.008B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.008B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.007B | 0.00 |
| Avinger (AVGR) | United States | $0.007B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.007B | 0.00 |
| InspireMD (NSPR) | Israel | $0.006B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.006B | 0.00 |
| Amedica (SINT) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
